Progressive multiple sclerosis
- 3 September 2009
- journal article
- review article
- Published by Springer Nature in Seminars in Immunopathology
- Vol. 31 (4) , 455-465
Abstract
Multiple sclerosis (MS) is a chronic inflammatory, demyelinating disease of the central nervous system, which starts in the majority of patients with a relapsing/remitting MS (RRMS) course , which after several years of disease duration converts into a progressive disease. Since anti-inflammatory therapies and immune modulation exert a beneficial effect at the relapsing/remitting stage of the disease, but not in the progressive stage, the question was raised whether inflammation drives tissue damage in progressive MS at all. We show here that also in progressive MS, inflammation is the driving force for brain injury and that the discrepancy between inflammation-driven tissue injury and response to immunomodulatory therapies can be explained by different pathomechanisms acting in RRMS and progressive MS.Keywords
This publication has 108 references indexed in Scilit:
- The relation between inflammation and neurodegeneration in multiple sclerosis brainsBrain, 2009
- Conduits Mediate Transport of Low-Molecular-Weight Antigen to Lymph Node FolliclesImmunity, 2009
- Lymphotoxin β receptor signaling promotes tertiary lymphoid organogenesis in the aorta adventitia of agedApoE−/− miceJournal of Experimental Medicine, 2009
- Review: Mitochondria and disease progression in multiple sclerosisNeuropathology and Applied Neurobiology, 2008
- Neuroinflammation Associated with Aging Sensitizes the Brain to the Effects of Infection or StressNeuroimmunomodulation, 2008
- Identification of soluble TREM-2 in the cerebrospinal fluid and its association with multiple sclerosis and CNS inflammationBrain, 2008
- Mitochondrial defects in acute multiple sclerosis lesionsBrain, 2008
- Development of Secondary Lymphoid OrgansAnnual Review of Immunology, 2008
- The Immunopathology of Multiple Sclerosis: An OverviewBrain Pathology, 2007
- Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammationNature, 2002